← Leaderboards
Alexander Theodore Sougiannis
University Of South Carolina At Columbia
$97,866
Attributed
$97,866
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36.4K · FY2018–20$50K$37.5K$25K$12.5K$0
'18
'19
'20
Funding mix
By agency
NIH$97,866 · 1
By mechanism
F31$97,866 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Elizabeth Angela Murphy$6,337,319
- Kandy T Velazquez$2,636,909
- Ciaran Fairman$362,170
- James A Carson$3,645,457
- H Trent Spencer$5,129,255
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsAppetite LossAreaBacteriaBehavioral OutcomeCancer TherapyChemotherapeutic AgentChemotherapyChinese PeopleChronic Kidney FailureClinical TrialsColorectal CancerColorectal Cancer TreatmentCommensal BacteriaCostDiarrheaDietDrug UsageEmodinEnvironmentExhibitsFatigueFluorouracilAnthraquinones
Grant awards (3)
Enhancing the efficacy of 5 fluorouracil using emodin as a complementary therapeutic$25,540
F31 · FY2020 · AT · contact PI
Enhancing the efficacy of 5 fluorouracil using emodin as a complementary therapeutic$36,409
F31 · FY2019 · AT · contact PI
Enhancing the efficacy of 5 fluorouracil using emodin as a complementary therapeutic$35,917
F31 · FY2018 · AT · contact PI